Agenda
Introduction | 12:30-12:35 |
Sonya Ghobrial, Consumer Healthcare Head of Investor Relations | |
Delivering shareholder value | 12:35-12:40 |
Emma Walmsley, Chief Executive Officer GSK | |
Haleon: A global consumer healthcare leader delivering sustainable | 12:40-13:10 |
above market growth and attractive returns | |
Brian McNamara, Chief Executive Officer Designate Haleon | |
Competitive capabilities to outperform in the market | 13:10-13:35 |
Tamara Rogers, Chief Marketing Officer & Franck Riot Head of R&D | |
Break | 13:35-13:50 |
Delivering attractive growth across the regions | 13:50-14:45 |
Lisa Paley, Head of U.S. & North America | |
Keith Choy, Head of Asia Pacific | |
Filippo Lanzi, Head of EMEA & LatAm | |
Break | 14:45-15:00 |
Running a responsible business, integral to all we do | 15:00-15:20 |
Teri Lyng, Head of Sustainability | |
Committed to delivering attractive & sustainable growth, | 15:20-15:50 |
maximising shareholder value | |
Tobias Hestler, Chief Financial Officer Designate Haleon | |
Bringing it all together | 15:50-15:55 |
Brian McNamara, Chief Executive Officer Designate Haleon | |
Short break ahead of Q&A | 15:55-16:00 |
Q&A | 16:00-17:00 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GSK - GlaxoSmithKline plc published this content on 28 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 February 2022 12:34:08 UTC.